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Summa,-r W'e examined levels of mRNA and protein for N-cadhein. the predominant cadhenrn in neural
tissues, and mRNNA levels for the cadherin-associated protein. x-catenin. in a senes of gliomas and in
glioblastoma cell lines. mRNA levels for N-cadhenrn and c-catenin were significantly higher in glioblastomas
than in low-erade astrocvtomas or normal brain. while the levels of intact N-cadherin protein were similar in
glioblastomas. low-grade astrocvtomas and brain. In addition. there A-as no consistent relationship betv-een
invasiveness and expression of N-cadhenin and ci-catenin in highly invasive vs minimally invasive tumours
A-ithin the same histopathological grade. To assess further the relationship between cadherin expression and
neural tumour invasion, we measured N-cadherin expression. calcium-dependent cell adhesion and motility of
several glioblastoma cell lines. While all N-cadhenrn-expressing lines u-ere adhesive, no correlation was seen
between the level of N-cadherin expression and cell motility; Together. these findings imply that, in contrast to
the role played by E-cadhenrn in carcinomas. N-cadherin does not restnrct the invasion of glioblastomas.
KeN-words invasion, cell motility-, cell adhesion: brain tumours
The prognosis for patients with malignant primanr brain
tumours remains poor. in large part because the invasiveness
of these tumours limits the effectiveness of local therapies
such as surgery (Kellv et al.. 1987: Burger et al.. 1988).
Although the acquisition of invasive capacity bv cancer cells
during tumour progression has not been fullv analysed, alter-
ations of cell-cell adhesion, increases in cell motility and
secretion of proteolI-tic enzymes seem likely to be involved
(Liotta et al.. 1991). The suggestion that cell-cell adhesion
might be an important determinant of insvasion stems from
the observation that the mutual adhesiveness of squamous
cell carcinomas is weaker than that of corresponding normal
cells (Coman 1944. 1947). Progress in identification and char-
acterisation of cell-cell adhesion molecules (CAMs) (Take-
ichi. 1988: Cunningham et al.. 1990: Albelda and Buck. 1990)
has made it possible to determine whether changes in expres-
sion or activity of specific CAMs contribute to the invasi've
or malignant potential of different tumours. Recent studies
indicate that E-cadherin. the major adhesion molecule found
in epithelial cells (Takeichi. 1988). inhibits the motility and
invasion of carcinoma cells (Chen and Obrink. 1991: Frixen
et al.. 1991: Vleminckx et al.. 1991).
E-cadherin is one member of the cadherin family, which
are transmembrane glycoproteins that mediate Ca>--depen-
dent cell-cell adhesion (Takeichi. 1988). Classical cadherins
consist of a large extracellular domain that contains five
homologous segments with calcium-binding motifs, a trans-
membrane domain and a cytoplasmic domain. Cadherins
mediate adhesion by a homophilic mechanism. i.e. cadherin-
to-cadherin bindinz (Nagafuchi et al.. 1987) and the
specificity of this binding is determined by the amino-
terminal homologous repeat segment (Nose et al.. 1990).
Cadhenrns are linked to the cvtoskeleton bv means of cvto-
plasmic proteins, termed c-. and y-catenins (Ozawa et al..
1989: Ozawa and Kemler. 1992). which bind to a region of
70 amino acids in the cytoplasmic domain of cadherins.
Binding of catenins is essential for effectiv-e cadherin-
mediated adhesion (Nagafuchi and Takeichi. 1988: Ozawa et
al.. 1990).
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Although other CAMs are coexpressed w-ith cadherins in
most cells. the cadherins appear to play the predominant role
in cell-cell adhesion. Blocking cadherin activity with
antibodies not only prevents reassociation of dispersed cells.
but also dissociates adherent cells in culture or from intact
embry onic tissues (Takeichi et al.. 1981: Shirayoshi et al..
1983). In contrast. inactivation of other adhesion molecules
has little effect on adhesiveness of cells as long as cadherins
are intact (Duband et al.. 1987). In addition to mediating
adhesion. cadherins appear to affect cell differentiation and
behaviour. When cadherins are introduced into fibroblasts or
sarcoma cells via transfection. the cells assume a more
epithelioid morphology- with the development of specialised
junctions (Takeichi. 1988). Cadherin-mediated contact also
induces cell differentiation (Shiravoshi et al.. 1983). These
results imply that changes in expression of cadherins might
have profound effects on cell behaviour.
In carcinoma cells, loss of E-cadherin correlates directly
with increased malignancy and invasiveness in Oi,o (Schipper
et al.. 1991: Shiozaki et al.. 1991: Sommers et al.. 1991:
Mayer et al.. 1993: Rasbridge et al.. 1993). In addition.
transfection of epithelial cells or fibroblasts with E-cadherin
suppresses their invasion in *itro. while loss of E-cadherin
correlates with enhanced invasiveness (Behrens et al.. 1989:
Chen and Obrink. 1991: Frixen et al.. 1991: Vleminckx et al..
1991). These observations strongly suggest that E-cadherin-
mediated adhesion regulates tumour cell invasion. This con-
clusion is strengthened by closer analy-sis of some tumours
that are invasive yet retain levels of E-cadherin: in these cells.
x-catenin expression is greatly reduced, resulting in reduced
E-cadherin-mediated adhesion (Shimoyama et al.. 1992: Mor-
ton et al.. 1993: Kadowaki et al.. 1994). Although these
observations establish that E-cadherin inhibits tumour cell
invasion, the mechanism by u-hich this occurs is not vet fully
understood.
In contrast to E-cadherin. little is know-n about the rela-
tionship between expression of neural cadherins and invasion
of astrocytomas. Several cadherins are enriched in neural
tissue, including N-cadherin (Hatta and Takeichi. 1986:
Hatta et al.. 1987). B-cadherin (Napolitano et al.. 1991).
R-cadherin (Inuzuka et al.. 1991) and T-cadherin (Ranscht
and Dours-Zimmerman. 1991). Recently. PCR methods have
been used to identify additional neural cadherins (Suzuki et
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al.. 1991). Of these. N-cadherin has been most extensiveix
investigated. Within the central nervous system. N-cadhenn
is expressed by both neurons and astrocytes (Hatta et al..
1987: Tomaselli et al.. 1988). but the molecule is not
restricted to the ner ous sy-stem and is also abundant in
skeletal (Hatta et al.. 1987) and cardiac muscle (Duband et
al.. 1987). A fragment of N-cadherin can be released from
the cell surface by proteol,-tic cleavage and accumulate in
vio, as in the vitreous bodv (Paradies and Grunwald. 1993).
Although this soluble fragment retains adhesive activity
(Paradies and Grunwald. 1993). little is known about the
physiological effects of such release. In neurons. adhesion
mediated bv N-cadherin triggers a cascade of second
messengers. culminating in the influx of calcium. which
induces extension of neuronal processes (Doherty et al..
1991). The effects of N-cadherin-mediated contact on the
motilitx and invasion of normal astroc,-tes and astrocvtoma
cells. however, have not been described.
In this studv. we compared the expression of N-cadherin
and a-catenin in normal brain tissue. low-grade astrocytomas
and malignant gliomas. to determine whether changes in this
cadherin adhesion system might play a role in the enhanced
invasion of glioblastoma cells. We also examined expression
of N-cadherin and a-catenin in a series of human glioblas-
toma cell lines and tested whether cadherin-mediated
adhesion correlated w-ith the motilitv of these cells in in vitro
assavs. The results indicate that N-cadherin and a-catenin
levels remain the same or increase in high-grade gliomas. In
addition. we found no relationship between cadherin-
mediated adhesion and motilitv in the glioblastoma cell lines.
Together. these findings suggest that. in contrast to E-
cadherin in carcinomas. N-cadherin does not regulate tumour
cell invasion in astrocv tic tumours.
-Materials and methods
Tumour specimens and cell lines
Tumour specimens A-ere obtained from a tumour bank main-
tained bv the Brain Tumour Research Center at The Umiver-
sitv of Cincinnati Colleze of Medicine. The tissues were snap
frozen in liquid nitrogen immediately after resection. The
samples included one pilocytic astrocvtoma. four low-grade
astrocvtomas. three anaplastic astrocytomas. nine glioblas-
tomas. two mixed zliomas. two oligodendrogliomas and a
specimen of normal brain obtained from an epilepsy patient.
Tumour specimens were classified according to the WHO
sy-stem. in u-hich grade I corresponds to pilocytic ast-
rocytomas. grade II to low-grade astrocvtomas. grade III to
anaplastic astrocvtomas and grade IV to glioblastomas.
Patient identitv was not disclosed but the results of his-
topathological analysis and limited clinical information were
made available for correlation with the analx ses of cadherin
and catenin expression. Magnetic resonance (MR) images
obtained durinz the course of treatment were reviewed to
assess whether the tumours remained localised (termed
minimally invasive') or diffusely infiltrated surrounding brain
tissue (termed 'highly invasive'). Samples of normal brain.
heart. liver and placenta w-ere analysed as controls. In addi-
tion, seven glioblastoma cell lines were analysed, including
U-87MG. U-1 18MG. U-138MG. U-373MG. T98G. Hs683
(Ponten and Maclntvre. 1968: Owens et al.. 1976: Stein.
1979). obtained from the American Type Culture Collection
(Rockville. MD. USA). and SNB-19 (Gross et al.. 1988).
obtained from the Tumor Depositorv. Developmental Thera-
peutics Program. Divsion of Cancer Treatment. National
Cancer Institute.
Northern blot analysis of tumour and cell line RNA4
Total RNA was extracted from human gliomas and glioblas-
toma cell lines by a single-step isolation method (Chomczvn-
ski and Sacchi. 1987). The levels of mRNA for N-cadherin
and x-catenin were compared by Northern blot analysis.
Twentv micrograms of total RNA from each sample was
fractionated by denaturing agarose gel electrophoresis and
then transferred to nylon membranes (Micron Separation.
Westborough. MA. USA). For analysis of glioblastoma cell
lines, total RNA was extracted from seven glioblastoma cell
lines at different stages of confluency: semiconfluent (SC).
immediately after reaching confluencv (IC) or 4-5 davs after
reaching confluency (C).
The cDNA probe for N-cadherin was the middle EcoRI
fragment (approximately 300 base pairs) of the sequence
reported by Reid and Hemperlv (1990). The cDNA probe for
x-catenin contained the entire open reading frame of a-
catenin (Oda et al.. 1993). Because of the close similanrtv in
sequence. this probe recognises both cx-E-catenin and x-N-
catenin. Probes for Northern blots were labelled using the
Prime-It random primer labelling kit according to the
manufacturer's instruction (Stratagene. La Jolla. CA. USA).
As an internal control for the amount of RNA loaded in
each well, a 20mer oligonucleotide probe for 18S RNA
(GACAAGCATATGCTACTGGC) (McCallum and Maden.
1985) -as end labelled with [y-"P]dATP and used according
to previously published methods (Church and Gilbert. 1984).
Hv-bridisation of RNA blots was performed by standard
methods (Selden. 1992). RNA blots w-ere washed with
2 x SSC and 0.10o SDS for 30 mnmn at room temperature and
with 0.2 x SSC and 0.lIo SDS for 30 min at 55C. covered in
Saran Wrap. and autoradiographed overnight at -20°C.
Relative hvbridisation intensities were determined by use of a
phosphorimager. The values for N-cadherin or a-catenin
were corrected for variations in loading by dividing bx the
values obtained for 18S RNA. For ease of comparison in
Table I. all N-cadherin and a-catenin values were normalised
to the values obtained from tumour GBM1. which were set
to 0.2. Similarly. in Table II. all N-cadherin and a-cateniin
values w-ere normalised to the values obtained from SNB-19
(IC). -hich were set to 1.0.
Immunoblot analysis of tumour samples andglioblastoma cell
lines
Glioblastoma cell lines were washed with 0.24% Hepes
buffer, scraped and centrifuged. After removal of super-
natant. an equal volume of 1 x Laemmli buffer (Laemmli,
1970). 5 mm EDTA. 100 glI of phenlmnethylsulphonyl
fluoride. 1 mm leupeptin. 1 1Am pepstatin and 100 tLm
iodoacetamide was added and the pellets were boiled for
5 mn. Normal brain tissue removed from an epilepsy patient.
astrocytomas and a sample of chicken heart (a positive con-
trol for N-cadherin) were homogenised in an equal volume of
the buffer described above and boiled for 5 mn. Equal
volumes (10 l per lane) of each extract were separated by
using 75%0 polyacnrlamide gels and transferred onto nit-
rocellulose membranes. After blocking with 5% dry milk in
TBS (10 mm Tris-HCl pH 7.5. 150 mm sodium chloride), the
membranes were incubated with primary antibodies over-
night. After electrophoresis. the protein content of each
extract was quantified by the Bio-Rad protein assay kit
(Bio-Rad. Hercules. CA. USA) and the extracts were found
to contain similar levels of protein that, in no case. varied
more than 2-fold. In addition, the relative level of loading
and effectiveness of transfer were verified by cutting off the
lower part of the nitrocellulose filter and staining with 0.1%
amido black. For detecting N-cadherin. we used the
monospecific poly'clonal antiserum C-NCAD (raised against
a synthetic peptide correspondin*g to amino acids 838-856)
(Lagunowich et al.. 1990) (generously provided by J Grun-
wald). which recognises the cvtoplasmic region near the car-
boxyl terminus. After washing. the membrane was incubated
with alkaline phosphatase-conjugated goat anti-rabbit IgG
(H + L) (Bio-Rad Laboratories). After washing. the bands
were visualised with nitroblue tetrazolium chloride and 5-
bromo-4-chloro-3-indolylphosphate p-toluidine salt (Gibco
BRL. Gaithersburg. MA. USA).Expre-sion d N-caderin and d-catein in astroymas
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Cell aggregation assai
This assay was carried out as described previously (Bracken-
bury et al., 1977. 1981). In brief, glioblastoma cell lines
growing in tissue culture dishes were rinsed with Hepes buffer
containing 1 mM calcium chloride, then incubated in 0.04%
recrystallised trypsin (Worthington) in Hepes buffer supp-
lemented with 10mM calcium chloride and 100fggm'-l
DNAse. Cells were then centrifuged and resuspended in
Hepes buffer with 1 mM calcium chloride and lOO1ig ml-'
DNAse. Then, 2 x 106 cells were added to approximately
2 ml of Hepes buffer with 1 mM calcium chloride or 1 mM
EDTA. Initial cell numbers (No) were determined using a
Coulter counter (Coulter Electronics, Hialeah, FL, USA)
and, after shaking incubation for 30 mn at 37°C, the cell
numbers (Nm) were counted again. The percentage aggrega-
tion was calculated from the formula No - NmINO x 100.
Assays were repeated at least three times and averages were
calculated.
Woundfilling assay
Glioblastoma cell lines were grown to confluency in tissue
culture dishes. At three places within each dish, a small
region was scraped with a P-200 plastic pipette tip to produce
a cleared path (wound') of almost constant width. The
wounds were observed by phase-contrast microscopy at
roughly 12 h intervals after scraping, and the time when each
wound was totally filled by cells was noted. In two
experiments, the times of complete filling did not vary.
were highly invasive tumours while GBM6 and GBM9 were
minimally invasive. Similarly, GBM5 and GBM8 expressed
roughly similar amounts of N-cadherin mRNA, higher than
the level expressed in GBMl, GBM6. GBM7 and GBM9; of
these tumours, GBM5 was highly invasive while GBM8 was
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Figre 1 N-cadherin and m-catenin mRNA levels in astrocy-
tomas. The figure shows an autoradiograph of Northern blot
analysis of total RNA (20gg per lane) extracted from glioblas-
toma multiforme tumours (GBM) classified as WHO grade IV;
anaplastic astrocytomas (AGrIII) classified as WHO grade III;
low grade astrocytomas (LGA) classified as WHO grade II; a
pilocytic astrocytoma (PILO) classified as WHO grade I; and a
normal brain sample (NB). In one case (GBM5) two different
samples from the same tumour were analysed. Blots were hyb-
ridised with cDNA probes for N-cadherin (top) and m-catenin
(middle) and with an oligonucleotide probe for 18S rRNA (bot-
tom).
Resuhs
Expression ofN-cadherin and a-catenin mRNA in
astrocytomas, gliomas andglioblastoma cell lines
To determine whether alterations in the N-cadherin adhesion
system might contribute to invasive potential, we compared
the expression of mRNA for N-cadherin and the associated
protein a-catenin in normal brain and gliomas of varying
grades. RNA was extracted from snap-frozen tissues and
analysed by Northern blots. Figure 1 shows data from
Northern blots hybridised with radiolabelled probes for N-
cadherin and x-catenin. An N-cadherin cDNA probe recog-
nised RNA transcripts of 4.0 and 4.3 kb, as previously
reported (Walsh et al., 1990). The E-catenin probe reacted
with a single transcript of 3.8 kb (Oda et al., 1993). To
compare the levels of N-cadherin and x-catenin mRNA in
different samples, the blots were also hybridised with an
oligonucleotide probe for 18S RNA as a measure of the
amount of RNA loaded. These blots and others were then
quantified by scanning with a phosphorimager, the amounts
of mRNA for N-cadherin and a-catenin in each sample were
normalised relative to 18S RNA, and the values tabulated
(Table I). Replications of the same tumour specimens were
generally consistent, and comparison of the different tumour
specimens revealed that N-cadherin was expressed at
significantly higher levels in anaplastic astrocytomas and
glioblastomas than in low-grade astrocytomas and normal
brain (Table I). The difference between these groups was
highly significant (P<0.05 in Student t-test). The a-catenin
transcript was also expressed at significantly higher levels in
high-grade gliomas than in low-grade astrocytomas and nor-
mal brain, which contained very low levels ofN-cadherin and
cz-catenin mRNAs.
Although higher grade tumours are generally more
invasive, this is not invariably the case. We therefore com-
pared the expression of N-cadherin among tumours within a
single grade that vanred in invasiveness, as assessed by clinical
records, particulary MR scans. Although this analysis was
necessarily restricted by the limited number of samples, no
consistent relationship was seen between N-cadherin expres-
sion and invasion. For example, among the grade IV glio-
blastomas, GBM1, GBM6, GBM7 and GBM9 aH express
similar amounts of N-cadherin mRNA; GBM1 and GBM7
Table I Analysis of N-cadherin and x-catenin mRNA levels in
gliomas
Tumoura N-cadherin" m-cateninb
High-grade gliomas
GBM1 0.2. 0.2 0.2. 0.2
GBM2 0.61. 0.58 0.35. 0.70
GBM3 0.70. 0.32 0.54. 0.35
GBM4 0.50. 1.05 0.48. 0.73
GBM5 0.60. 0.57 0.46. 0.40
GBM6 0.31 0.30
GBM7 0.26 0.24
GBM8 047 0.48
GBM9 0.27 0.58
AGrIIII 0. 0.75 0. 0.68
AGrIII2 0.3. 0 0.33. 0
AGrIII3 0 0.13
Low-grade gliomas
LGA1 0. 0 0. 0
LGA2 0.19. 0 0.14. 0
LGA3 0. 0.09 0. 0.33
LGA5 0.12. 0.21 0.12. 0.17
Other tumours
PILO 0.11. 0.12 0.17, 0.30
MGI 0 0
MG2 0 0
OLIGOI 0 0
OLIGO2 0 0
Control tissues
Normal brain 0.18 0.07
Heart 0.72. 0.95 0.42, 0
Liver 0. 0.17 0. 0
Placenta 0. 0 0. 0
'RNA wasextracted from tumour specimens (see legend to Figure 1).
analysed by Northern blot and quantified by use ofa phosphorimager.
asdescribed in Materials andmethods. The tablepresentsdata from the
blot shown in Figure 1 combined with data from other similar blots.
bRelative hybridisation intensities were determined by use of a
phosphorimager. Thevalues for N-cadherin or x-cateninwerecorrected
for variations in loading by dividing by the values obtained for 18S
RNA. Foreaseofcomparison. allN-cadherinandm-cateninvalueswere
normalised to the values obtained from tumour GBM1. which were set
to 0.2.
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minimally invasive. As another example, within grade III.
AGIII2 was highly invasive, whereas AGIII3 was very
localised; when corrected for differences in loading, these
tumours expressed similar levels of N-cadherin mRNA.
Finally, although there was significant variation in the level
of mRNAs for N-cadherin and cx-catenin in different gliomas
(Table I), the ratio between the two mRNAs was generally
similar (linear regression and correlation analysis yielded
values of r = 0.838 and P = 0.000).
We also compared the expression of mRNA for N-
cadherin and the associated protein x-catenin in several
established human glioblastoma cell lines. RNA was ex-
tracted from cells harvested at different states of confluence
analysed by Northern blots. The seven glioblastoma cell lines
also expressed elevated levels of N-cadherin and x-catenin
mRNA relative to normal brain (Figure 2 and Table II). In
contrast to the tumour specimens, however, there was no
correlation between the levels of N-cadherin and rx-catenin
mRNA in the cell lines. In addition, mRNA levels for both
molecules varied as a function of cell density, although there
was no consistent pattern of density-dependent expression
among the various cell lines.
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Expression ofN-cadherin protein in gliomas andglioblastoma
cell lines
To assess the levels of N-cadherin protein. tumour samples
and glioblastoma cell lines were extracted with non-ionic
detergents. Equal volumes of each extract were separated by
gel electrophoresis. transferred to nitrocellulose and blotted
with antibodies against N-cadherin. Subsequent protein
determinations indicated that roughly equal amounts of
protein were loaded. As shown in Figure 3. antibodies to
N-cadherin detected a band of approximately 120 kDa in
extracts of all astrocytomas and in normal brain that co-
migrated with a band in the positive control extract from
chicken heart. The different astrocytoma tumour samples
generally contained similar levels of N-cadherin. Although
slightly lower levels of N-cadherin were seen in the GBM11
extract, the pattern of amido black staining suggested that
there was some degradation of the proteins in this extract.
N-cadherin was also detected in extracts of all glioblastoma
cell lines (Figure 4), although the levels varied somewhat.
The U-87MG and T98G lines expressed relatively low levels
of N-cadherin, while the U-373MG and SNB-19 lines ex-
pressed relatively high levels.
208-
0 115-
x
>- 79-
es ) r- v
2 m
2 02
CD CD CD CD 0
-J -J
0 -J m 1
z .
18S .. _
.. ... ...
Fire 2 mRNA expression of N-cadhenrn and m-catenin in
glioblastoma cell lines at different cell densities. The levels of
mRNA for N-cadherin (top) and a-catenin (middle) isolated from
seven glioblastoma cell lines at different cell densities were
assessed by Northern blotting as described in the legend to
Figure 1. RNA was extracted from cells that were semiconfluent
(SC). immediately after the cells became confluent (IC) or 4-5
days after the cells became confluent (C). Normal brain (NB) was
used as a positive control.
Table II Analysis of N-cadhenin and m-catelni
glioblastoma cell lines
mRNA levels in
Figue 3 Protein expression of N-cadherin in astrocytomas and
glioblastoma cell lines. Relative levels of N-cadherin protein in
extracts from astrocytomas were determined by immunoblot
analysis using a polyclonal antiserum raised against a synthetic
peptide from the cytoplasmic domain of N-cadherin (Lagunowich
et al., 1990) as described in Materials and methods. The lower
part of each filter was stained with amido black to verify the
loading and transfer of extracts. Abbreviations used are: GBM,
glioblastoma multiforme; LGA, low-grade astrocytoma; PILO,
pilocytic astrocytoma; NB, normal brain; CH. chicken heart.
Cell line; V-cadheris't m-catenint
T98G(SC) 0.71 0.71
T98G(IC) 0.40 0.97
T98G(C) 0.36 1.90
U-373MG(SC) 1.59 0.91
U-373MG(IC) 0.83 0.53
U-373MG(C) 1.21 1.03
SNB I9(SC) 0.70 0.84
SNB-19(IC) 1.00 1.00
SNB- 9(C) 0.71 0.95
Hs683(SC) 0.79 0.85
Hs683(C) 0.71 0.84
U-118MG(SC) 0.68 0.63
U-118MG(C) 0.83 0.92
U-87MG(SC) 0.38 0.84
U-87MG(C) 0.24 0.72
U-138MG(SC) 0.29 0.78
U-138MG(C) 0.63 0.77
'RNA was harvested from indicated cell lines at different stages of
confluency -semiconfluent (SC), immediately after reaching confluency
(IC) or 4-5 days after reaching confluency (C) - and analysed by
Northern blot. bRelative hybridisation intensities were determined by
use ofa phosphorimager. The values for N-cadherin or a-catenin were
corrected forvariations inloadingbydividingbythevaluesobtained for
18S RNA. For ease ofcomparison. all N-cadherin and a-catenin values
were normalised to the values obtained from SNB-19 (IC), which were
set to 1.0.
CD
oD CD CD
a, CD en) n r- CD
en
CO D D ~
z
m co
I m r
z cJ
208-
° 115-
x
:g 79-
Figue 4 Protein expression of N-cadherin in astrocytomas and
glioblastoma cell lines. Relative levels of N-cadherin protein in
extracts from glioblastoma cell lines were determined by
immunoblot analysis using a polyclonal antiserum raised against
a synthetic peptide from the cytoplasmic domain of N-cadherin
(Lagunowich et al., 1990) as described in Materials and methods.
The lower part of each filter was stained with amido black to
verify the loading and transfer of extracts. Abbreviations used
are: NB, normal brain: CH, chicken heart.Table m Cell aggregtion and wound filling assays of glioblastoma
cell lines
Cell line Cell adhesiona Woundfilhngb
U-87MG 40% (7%) 20h
U-118MG 65% (4%) NF
U-138MG 74% (7%) 60h
U-373MG 56% (21%) 56h
T98G 19% (4%) 68h
SNB-19 39% (9%) 20h
Hs683 39% (16%) lOdays
'Each cel line was analysed in three aggregtion assays, as described
in Materials and methods. The table shows the average values with
standard deviations in parentheses. bWound filling assays were carried
out twice, in triplicate, and the table shows the values that were
repeatedly obtained. NF, the wound was not filled completely.
Cell aggregation and motility ofglioblastoma cell lines
To test whether cadherin-mediated adhesion regulates cell
motility in the glioblastoma cell lines, we measured the
aggregation and motility of these cells in vitro and correlated
the results of these two assays with determinations of N-
cadherin expression. For cell aggregation assays, cells were
removed from culture dishes under conditions that retain
cadherins and were tested for their ability to reassociate. As
shown in Table III, the different glioblastoma lines showed
significant variation in calcium-dependent adhesion, ranging
from 19% (T98G) to more than 50% (U-138MG, U-118MG
and U-373MG).
To assess the motility of these cells, we employed an in
vitro assay that measures the ability of the cells to refill a
'wound' introduced into a confluent monolayer of cells by
scraping a path. U-87MG showed the shortest time for
wound healing (20 h), while the wound healing times of
U-118MG and Hs683 were very long (Table III). The times
required for refilling the wound varied substantially among
the glioblastoma cell lines and showed no consistent relation-
ship to the level of adhesiveness, as revealed in the cell
aggregation assays. In addition, motility in the wound
refilling assay did not show a consistent correlation with
expression of N-cadherin.
Dicassiom
Previous work suggests that the loss of E-cadherin that
occurs as tumours progress to less differentiated forms is an
important determinant of enhanced invasiveness (Takeichi,
1993). N-cadherin is the predominant cadherin in brain tis-
sues and appears to play a major role in maintaining the
multicellular structure of brain (Hatta et al., 1985). We
therefore tested whether expression of N-adherin might
regulate the invasive behaviour of astrocytomas. We found
that N-cadherin and a-catenin expression increases or re-
mains the same as astrocytomas progress to high-grade glio-
blastomas. In addition, no correlation was observed between
cadherin expression and cell motility in a series of glioblas-
toma cell lines. As discussed below, these results indicate that
the relationship between N-cadherin expression and invasion
is quite different from that of E-adherin.
To analyse the relationship between cell adhesion and
invasiveness of astrocytomas, we first surveyed the expression
of several cell adhesion molecules, including N-cadherin, N-
CAM, LI, E-cadherin and P-cadherin. in tumour samples.
Results from this initial survey (data not shown) indicated
that only N-cadherin and N-CAM, which contributes to cell
adhesion to a lesser extent than N-cadherin (Duband et al.,
1987), showed appreciable expression. The remainder of our
studies focused, therefore, on N-cadherin and the associated
protein, a-catenin.
In tumours, higher levels of mRNA for N-cadherin were
found in anaplastic astrocytomas (AA) and glioblastomas
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(GBM) than in low-grade astrocytomas or normal brain.
This observation was consistent, in that 8/11 AAs or GBMs
showed increased levels, although there was some variation
in the magnitude of this increase. If increased invasive
capacity resulted in part from loss of N-cadherin, then higher
grade gliomas might have been expected to show reduced
levels of N-cadherin expression, as is the case for E-cadherin
in adenocarcinomas (see Takeichi, 1993). These findings thus
suggested that loss of N-cadherin-mediated adhesion was not
a key determinant in the enhanced invasion of higher grade
tumours. One limitation to this analysis was that, although
higher grade tumours are generally more invasive, this is not
invariably the case. We therefore compared the expression of
N-cadherin among tumours within the same grade that were
judged, by examination of MR scans, to be highly or
minimally invasive. This analysis showed that there is no
consistent relationship between invasion and N-cadherin ex-
pression, confirming the conclusion that alterations in N-
cadherin levels do not appear to contribute to acquisition of
invasive capacity.
It was striking that, in all of the tumours examined, in-
creases in N-cadherin mRNA were accompanied by approx-
imately proportional increases in the levels of a-catenin
mRNA. The x-catenin probe used recognises both a-E-
catenin and a-N-catenin, but only a-N-catenin is expressed in
normal brain (Hirano et al., 1992). We presume therefore
that the elevated levels of a-catenin mRNA detected in
tumours correspond to a-N-catenin. If the correlation
between increased N-cadherin mRNA and x-catenin mRNA
is not simply fortuitous, this finding may suggest that expres-
sion of the two genes is coordinately controlled. In contrast,
a-catenin expression is greatly reduced in some epithelial
tumours that retain high levels of E-cadherin (Shimoyama et
al., 1992; Morton et al., 1993; Kadowaki et al., 1994), appar-
ently contributing to the invasive ability of the tumour cells.
In contrast to the increases in mRNA for N-cadherin,
immunoblot analysis suggested that normal brain, low-grade
astrocytomas and high-grade astrocytomas all contained
roughly similar levels of intact N-cadherin protein. Although
this apparent discrepancy could arise in several ways, one
intriguing possibility is that the N-cadherin protein produced
in the high-grade tumours is not completely destroyed, but,
by analogy with the situation known to occur during normal
retinal development (Paradies and Grunwald, 1993), is
cleaved to produce a soluble fragment that might retain some
biological activity. This possibility is consistent with our
findings, but could not be directly tested, because the
antibody used to detect N-cadherin reacts with the carboxyl-
terminal portion of the molecule, and thus would not detect
the soluble fragment.
Chen and Obrink (1991) have observed that cell contact
mediated by E-cadherin inhibits cell motility and have sug-
gested that this may be the means by which cadherins inhibit
invasion. We therefore evaluated the motility, calcium-
dependent adhesion and N-cadherin expression of several
human glioblastoma cell lines, to analyse further whether
there is any relationship between cadherin-mediated adhesion
and invasion of glioblastoma cells. As in the glioblastoma
tumours, all seven lines showed higher levels of N-cadherin
mRNA expression than found in normal brain or low-grade
astrocytomas. There were significant variations in calcium-
dependent adhesion among the different cell lines and, given
that other neural cadherins might be variably expressed by
these lines, it was perhaps not surprising that the variations
in adhesion did not appear to reflect differences in the levels
of N-adherin expression. The lines also showed significant
variations in motility, as assessed by their ability to refill
'wounds' made in a confluent monolayer of cultured cells
(the same assay used by Chen and Obrink). In contrast to the
relationship between E-cadherin mediated adhesion and
motility (Chen and Obrink, 1991), no consistent relationship
was seen in the glioblastoma cell lines between cadherin
expression and motility, although such a correlation could
have been obscured by variations in intrinsic levels of
motility.honfd Nadherin and nian inancyIoM oora N Shnoura etal
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The experiments described here were motivated by studies
of the relationship between E-cadherin expression and
invasion in carcinoma cells (Takeichi. 1993). The results of
our studies strongly suggest that changes in expression of
N-cadherin that occur during tumour progression differ from
those seen with E-cadherin and. further, that N-cadherin
does not appear to inhibit cell motility as E-cadherin does
(Chen and Obrink. 1991). These conclusions are further sup-
ported by our recent studies on the effects of E-cadherin and
N-cadherin on the motility and invasion of an astrocyte-like
cell line. WC5 (Paradies et al.. 1995). In those experiments,
E-cadherin expression reduced motility and invasion of WC5
cells. whereas expression of N-cadherin had little effect on
the rate of invasion.
In conclusion. these studies show that the expression of
N-cadherin mRNA and protein remain at equal or higher
levels in high-grade astrocytomas relative to low-grade astro-
cytoma or normal brain. Together with the finding that
glioblastoma cell lines show no consistent relationship
between N-cadherin expression and cell motility, the results
imply that expression of N-cadherin does not regulate
invasion of high-grade astrocytomas.
Acknowdgements
We thank Jerry Grunwald (Thomas Jefferson University, Philadel-
phia. PA. USA) for generously providing a polyclonal antibody
against N-cadherin. This work was supported by NIH Grant P20-
NS31145. NS was supported by a fellowship from the International
Medical Center (Tokyo. Japan) and NEP by a Dale DiVenti Fellow-
ship from the American Brain Tumor Association. HC was sup-
ported. in part. by NCI Training Grant CA59268-
References
ALBELDA S-M AND BUCK CA. (1990). Integnins and other cell
adhesion molecules. F4SEB J.. 4, 2868-2880.
BEHRENS J. MAREEL MM. vA.N ROY FM AND BIRCHMEIER W.
(1989). Dissecting tumor cell invasion: epithelial cells acquire
invasive properties after the loss of uvomorulin-mediated
cell-cell adhesion. J. Cell Biol.. 108, 2435-2447.
BRACKENBURY R. THIERY JP. RlUTISHAUSER U AND EDELMAN
GM. (1977). Adhesion among neural cells of the chick embryo. J.
Biol. Chem.. 252, 6835-6840.
BRACKENBURY R. RUTISHAUSER U AND EDELMAN GM. (1981).
Distinct calcium-independent and calcium-dependent adhesion
systems of chicken embryo cells. Proc. Natil Acad. Sci. USA, 78,
387-391.
BURGER PC. HEINZ ER. SHIBATA T AND KLEIHUES P. (1988).
Topographic anatomy and CT correlations in the untreated
glioblastoma multiforme. J. Neurosurg.. 68, 698-704.
CHEN W AND OBRINK B. (1991). Cell-cell contacts mediated by
E-cadherin (uvomorulin) restrict invasive behavior of L-eells. J.
Cell Biol.. 114, 319-327.
CHOMCZYNSKI P AND SACCHI N. (1987). Single-step method of
RNA isolation by acid guanidinium thiocyanate-phenol-
chloroform extraction. Anal. Biochem.. 162, 156-159.
CHURCH GM AND GILBERT W. (1984). Genomiic sequencing. Proc.
Vatl Acad. Sci. EUSA. 81, 1991-1995.
COMAN DR. (1944). Decreased mutual adhesiveness, a property of
cells from squamous cell carcinomas. Cancer Res., 4, 625-629.
COMAN DR. (1947). Mechanism of the invasiveness of cancer.
Science. 105, 347-348.
CUN.NIN'GHAM BA. EDELMAN GM AND THIERY J-P (eds). (1990).
Mforphoregulatory AMolecules. John Wiley: New York.
DOHERTY P. ASHTON SV. MOORE SE AND WALSH FS. (1991).
Morphoregulatorv activities of N-CAM and N-cadherin can be
accounted for by G protein-dependent activation of L- and N-
type neuronal Ca'- channels. Cell, 67, 21-33.
DUBAND JL. DUFOUR S. HATTA K. TAKEICHI M. EDELMAN GM
AND THIERY JP. (1987). Adhesion molecules during somito-
genesis in the avian embryo. J. Cell Biol., 104, 1361-1374.
FRIXEN UH. BEHRENS J. SACHS M. EBERLE G. VOSS B. WARDA A.
LOCHNER D AND BIRCHMEIER W. (1991). E-cadherin-mediated
cell-cell adhesion prevents invasiveness of human carcinoma
cells. J. Cell Biol.. 113, 173-185.
GROSS JL. BEHRENS DL. MULLINS DE. KORNBLITH PL AND DEX-
TER DL. (1988). Plasminogen activator and inhibitor activity in
human glioma cells and modulation by sodium butyrate. Cancer
Res.. 48, 291-2%.
HATTA K AND TAKEICHI M. (1986). Expression of N-cadherin
adhesion molecules associated with early morphogenetic events in
chick development. .Vature, 320, 447-449.
HATTA K. OKADA TS AND TAKEICHI M. (1985). A monoclonal
antibody disrupting calcium-dependent cell-cell adhesion of
brain tissues: possible role of its target antigen in animal pattern
formation. Proc. Natl .4cad. Sci. USA. 82, 2789-2793.
HATTA K. TAKAGI S. FUJISAWA H AND TAKEICHI M. (1987).
Spatial and temporal expression pattern of N-cadherin cell
adhesion molecule correlated with morphogenetic processes of
chicken embryos. Dev. Biol., 120, 215-227.
HIRANO S. KIMOTO N. SHIMOYAMA Y. HIROHASHI S AND
TAKEICHI M. (1992). Identification of a neural a-catenin as a key
regulator of cadherin function and multicellular organization.
Cell. 70, 293-301.
INUZUKA H. MIYATANI S AND TAKEICHI M. (1991). R-cadherin: a
novel Ca' -dependent cell-cell adhesion molecule expressed in the
retina. Neuron, 7, 69-79.
KADOWAKI T, SHIOZAKI H. I'OUE M. TAMURA S. OKA H. DOKI
Y. IHARA K. MATSUI S. IWAZAWA T. NAGAFUCHI A. T'SUKrTA
S AND MORI T. (1994). E-cadherin and x-catenin expression in
human esophageal cancer. Cancer Res.. 54, 291-296.
KELLY PH. DAUMAS-DUPORT C. KISPERT DB. KALL BA. SCHEIT-
HAUER BW AND ILLIG JJ. (1987). Imaging-based stereotaxic
serial biopsies in untreated intracranial glial neoplasms. J.
Neurosurg.. 66, 865-874.
LAEMMLI UK. (1970). Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature, 227, 680-685.
LAGUNOWICH LA. DONOSO LA AND GRUNWALD GB. (1990).
Identification of mammalian and invertebrate analogues of the
avian calcium-dependent cell adhesion protein N-cadherin with
synthetic peptide directed antibodies against a conserved cyto-
plasmic domain. Biochem. Biophys. Res. Commun., 172, 313-320.
LIOTFA LA. STEEG PS AND STETLER-STEVENSON WG. (1991).
Cancer metastasis and angiogenesis: an imbalance of positive and
negative regulation. Cell. 64, 327-336.
MCCALLUM FS AND MADEN BEH. (1985). Human 18S ribosomal
RNA sequence inferred from DNA sequence. Biochem. J. 232,
725-733.
MAYER B. JOHNSON JP. LEITL F. JAUCH KW. HEISS MM. SCHILD-
BERG FW. BIRCHMEIER W AND FUNKE I. (1993). E-cadherin
expression in primary and metastatic gastric cancer: down-
regulation correlates with cellular differentiation and glandular
disintegration. Cancer Res., 53, 1690-1695.
MORTON RA. EWING CM. NAGAFUCHI A. TSUKITA S AND ISAACS
WB. (1993). Reduction of E-cadhenrn levels and deletion of the
m-catenin gene in human prostate cancer cells. Cancer Res.. 53,
3585-3590.
NAGAFUCHI A AND TAKEICHI M. (1988). Cell binding function of
E-cadhenrn is regulated by the cytoplasmic domain. EM41BO J., 7,
3679-3684.
NAGAFUCHI A. SHIRAYOSHI Y. OKAZAKI K. YASUDA K AND
TAKEICHI M. (1987). Transformation of cell adhesion properties
by exogenously introduced E-cadherin cDNA. Nature, 329,
341-343.
NAPOLITANO EW. VENSTROM K. WHEELER EF AND REICHARDT
LF. (1991). Molecular cloning and charactenrzation of B-cadherin.
a novel chick cadherin. J. Cell Biol., 113, 893-905.
NOSE A. TSUJI K AND TAKEICHI M. (1990). Localization of
specificity determining sites in cadherin cell adhesion molecules.
Cell, 61, 147-155.
ODA T. KANAI Y. SHIMOYAMA Y. NAGAFUCHI A. TSUKITA S AND
HIROHASHI S. (1993). Cloning of the human cx-catenin cDNA
and its aberrant mRNA in a human cancer cell line. Biochem.
Biophys. Res. Commun.. 193, 897-904.
OWENS RB. SMITH HS. NELSON-REES WA AND SPRINGER EL.
(1976). Brief communication: epithelial cell cultures form normal
and cancerous human tissues. J. Natl Cancer Inst.. 56 843-849.
OZAWA M AND KEMLER R. (1992). Molecular organization of the
uvomorulin-catenin complex. J. Cell Biol., 116, 989-996.
OZAWA M. BARIBAULT H AND KEMLER R. (1989). The cytoplasmic
domain of the cell adhesion molecule uvomorulin associates with
three independent proteins structurally related in different species.
EMBO J.. 8, 1711-1717.E-prssiond N-cadherin andX-caein inasxrylma
N Shinoura etal
633
OZAWA M. RINGWALD M AND KEMLER R. (1990). Uvomorulin-
catenin complex formation is regulated by a specific domain in
the cytoplasmic region of the cell adhesion molecule. Proc. Natl
Acad. Sci. USA, 87, 4246-4250.
PARADIES NE AND GRUNWALD GB. (1993). Purification and char-
acterization of NCAD90. a soluble endogenous form of N-
cadherin. which is generated by proteolysis during retinal
development and retains adhesive and neurite-promoting func-
tion. J. Neurosci. Res., 36, 33-45.
PARADIES NE. KLOPFENSTEIN KJ AND BRACKENBURY R. (1995).
E-cadherin, but not N-cadherin, inhibits motility and reduces
invasion of RSV-transformed WC5 rat cerebellar cells. J. Cell
Biol., submitted for publication.
PONTEN J AND MACINTYRE EH. (1968). Long term culture of
normal and neoplastic human glia. Acta Pathol. Microbiol.
Scand., 74, 465-486.
RANSCHT B AND DOURS-ZIMMERMAN MT. (1991). T-cadherin. a
novel cadherin cell adhesion molecule in the nervous system lacks
the conserved cytoplasmic region. Neuron, 7, 391-402.
RASBRIDGE SA. GILLETT CE. SAMPSON SA. WALSH FS AND MIL-
LIS RR. (1993). Epithelial (E-) and placental (P-) cadherin cell
adhesion molecule expression in breast carcinoma. J. Pathol.,
169, 245-250.
REID RA AND HEMPERLY JJ. (1990). Human N-cadherin: nucleotide
and deduced amino acid sequence. NVucleic Acids Res., 18, 5896.
SCHIPPER JH. FRIXEN UH. BEHRENS J. UNGER A. JAHNKE K AND
BIRCHMEIER W. (1991). E-cadherin expression in squamous cell
carcinomas of head and neck: inverse correlation with tumor
dedifferentiation and lymph node metastasis. Cancer Res.. 51,
6328-6337.
SELDEN RF. (1992). Analysis of RNA by Northern hybridization. In
Current Protocols in Molecular Biology, Ausubel FM. Brent R.
Kingston RE, Moore DD. Seidman JG. Smith JA and Struhl K.
(eds) pp.4.9.1-4.9.8. Greene Publishing Associates and Wiley-
Interscience: Boston.
SHIOZAKI H. TAHARA H. OKA H. MIYATA M. KOBAYASHI K.
TAMURA S, IHARA K. DOKI Y. HIRANO S. TAKEICHI M AND
MORI T. (1991). Expression of E-cadherin molecules in human
cancers. Am. J. Pathol., 139, 17-23.
SHIMOYAMA Y. NAGAFUCHI A. FUJITA S. GOTOH M. TAKEICHI
M, TSUKITA S AND HIROHASHI S. (1992). Cadherin dysfunction
in a human cancer cell line: possible involvement of loss of
m-catenin expression in reduced cell-cell adhesiveness. Cancer
Res., 52, 5770-5774.
SHIRAYOSHI Y, OKADA TS AND TAKEICHI M. (1983). The calcium-
dependent cell-cell adhesion system regulates inner cell mass
formation and cell surface polarization in early mouse develop-
ment. Cell. 35, 631-638.
SOMMERS CL THOMPSON EW, TORRI JA. KEMLER R. GELMANN
EP AND BYERS SW. (1991). Cell adhesion molecule uvomorulin
expression in human breast cancer cell lines: relationship to mor-
phology and invasive capacities. Cell Grow-th Different., 2,
365-372.
STEIN GH. (1979). T98G: an anchorage-independent human tumor
cell line that exhibits stationary phase GI arrest in vitro. J. Cell.
Physiol., 99, 43-54.
SUZUKI S. SANO K AND TANIHARA H. (1991). Diversity of the
cadherin family: evidence for eight new cadherins in nervous
tissue. Cell Regulat., 2, 261-270.
TAKEICHI M. (1988). The cadherins: cell-cell adhesion molecules
controlling animal morphogenesis. Development. 102, 639-655.
TAKEICHI M. (1993). Cadherins in cancer: implications for invasion
and metastasis. Curr. Opin. Cell Biol.. 5, 806-811.
TAKEICHI M. ATSUMI T. YOSHIDA C. UNO K AND OKADA TS.
(1981). Selective adhesion of embryonal carcinoma cells and
differentiated cells by Caz+-dependent sites. Dev. Biol.. 87,
340-350.
TOMASELLI KJ, NEUGEBAUER KM. BIXBY JL LILIEN J AND
REICHARDT LF. (1988). N-cadherin and integrins: two-receptor
systems that mediate neuronal process outgrowth on astrocytes.
Neuron, 1, 33-43.
VLEMINCKX K. VAKAET Jr L, MAREEL M. FIERS W AND ROY FV.
(1991). Genetic manipulation of E-cadherin expression by
epithelial tumor cells reveals an invasion suppressor role. Cell. 66,
107-119.
WALSH FS. BARTON CH. PUITT W. MOORE SE. KELSELL D, SPURR
N AND GOODFELLOW PN. (1990). N-cadherin gene maps to
human chromosome 18 and is not linked to the E-cadherin gene.
J. Neurochem., 55, 805-812.